Science1 distinct publisher3 min readUpdated
A Nagoya University team reports DNA assembly two to five times more efficient than restriction enzymes plus T4 ligase, mostly by recovering more product and leaving longer overhangs.
The Scientist · Science desk

Compiled by The ScientistSomething wrong?How this is made
Researchers at Nagoya University and Gifu University report that silver nanoparticles can cut chemically modified DNA at defined sites and leave overhangs long enough to raise fragment-joining efficiency two to five times above conventional restriction enzyme methods, in work published in Nucleic Acids Research [1][2][3]. That matters because assembly efficiency, not cutting, is what caps how large a construct a lab can build in a reasonable number of rounds.
The standard route uses restriction enzymes to cut and T4 DNA ligase to join [4]. Restriction enzymes only recognise certain sequences, and the sticky ends they leave are relatively short, which drags on joining efficiency [5]. The team led by Professor Hiroshi Abe and Assistant Professor Masahito Inagaki, with Professor Natsuhisa Oka at Gifu University, went looking for a chemical cut instead [6].
They went back to a reaction reported between 1990 and 1992, in which silver ions cleave 3'-thiol-modified DNA at specific sites [7]. The cut site is therefore set by where the thiol modification sits in the strand, not by a recognition sequence. The original chemistry had a fatal yield problem: silver ions also bound nonspecifically and caused precipitation, and only about 14 percent of the DNA came back [8].
Swapping ions for nanoparticles fixed the recovery problem in two ways. Nanoparticles can be spun out of the mixture by centrifugation [9], and unwanted fragments stayed stuck to the particle surfaces while the fragments carrying sticky ends stayed in solution, which the group describes as a built-in purification step [11]. Recovery went from 14 percent to 98 percent, a sevenfold change [11][12].
The temperature numbers are where the practicality argument sits. Bare nanoparticles cleaved about 50 percent of the DNA at 70C and close to 100 percent at 95C within two hours, temperatures that damage long DNA [10]. Coating the particles with polyethylene glycol raised cleavage from 36 percent to 92 percent at 37C, but that run took 31 hours [13]. Inagaki, the study's first author, says optimised conditions reached above 91 percent cleavage at 50C within one to two hours [14].
On the assembly side, the nanoparticles produced 8-base sticky ends, which the authors say are hard to generate with conventional restriction enzymes, and T4 ligase joined those fragments about twice as efficiently as the traditional route [15]. The fivefold figure is the top of the reported two-to-five-times range [3]; the source material available here is cut off before it specifies which overhang length delivers it, so treat the 2x at 8 bases as the number that is actually pinned to a length.
Two things are worth watching. First, the full paper's overhang-length series: if efficiency scales cleanly from 8 bases upward, the fivefold claim becomes a design parameter rather than a headline. Second, whether the 50C, one-to-two-hour window holds on the long DNA molecules this is meant to serve, since the whole reason for the PEG coat was that hot cleavage damages exactly those substrates [10][13]. Nagoya's stated targets are gene therapies, cancer vaccines, engineered drugs and advanced crops [16], none of which has yet been shown built this way.
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
The technique produced DNA assembly efficiencies two to five times higher than those achieved with conventional restriction enzyme methods.
Researchers in Japan developed a method using silver nanoparticles to cut and reconnect DNA at targeted sites; the work was reported by Nagoya University on August 19, 2026.
Silver nanoparticles allowed the researchers to produce DNA fragments with 8-base sticky ends, which are difficult to generate using conventional restriction enzymes; when T4 DNA ligase was used to connect those fragments, joining efficiency was about twice as high as with traditional methods.
Standard methods for assembling long DNA molecules typically use restriction enzymes to make cuts and T4 DNA ligase to connect the resulting fragments.
Restriction enzymes can only recognize and cut certain DNA sequences, and they tend to produce relatively short sticky ends, which can reduce joining efficiency.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Quantified peer-reviewed result, single institutional voice
The claims are specific and internally consistent - stated cleavage percentages at named temperatures, a 14%-to-98% recovery figure, overhang-by-overhang ligation efficiencies, and a GFP/HeLa functional check - and are attributed to a Nucleic Acids Research paper. But every number in the cluster reaches us through one outlet relaying one institutional release, with no DOI or paper title supplied, no independent replication, and no outside expert assessment, which caps evidentiary strength.
No adoption signal in supplied material
The supplied source reports only the originating team's own bench results and one functional check in HeLa cells. There is no third-party lab use, kit or reagent availability, licensing, pricing, partner, or usage disclosure of any kind, and the team states that even simultaneous multi-fragment joining is unconfirmed. Inferring adoption from a research announcement would be guessing.
Headline range and application list run ahead of a two-fragment demo
The underlying numbers are real and specific, so this is not empty hype, but the packaging overstates reach in two ways. The 'up to 5x' headline rests on an 18-base versus 4-base overhang comparison rather than the 8-base case the story leads with, and the summary escalates a two-fragment ligation plus GFP expression test into simplifying construction of large DNA for gene therapies, cancer vaccines, engineered drugs and advanced crops - while the team itself says multi-fragment joining still needs confirmation before genome-scale DNA is in reach.
Institutional promotion with grant-funded authors as sole voice
The item is explicitly sourced to Nagoya University and carries the researchers' own forward-looking quotes, with acknowledged JST and AMED grant support listed at the end. Universities and grant-funded teams have a direct interest in emphasizing practical impact, and the aggregating publisher adds no counter-voice, verification, or competing-method comparison. No commercial entity, licensing arrangement, or vendor interest is disclosed in the material, so the incentive is reputational and funding-related rather than sales-driven.
Consistent single-source account, unverified externally
Confidence is moderate-low. The narrative is coherent, quantitatively detailed, and attributed to a peer-reviewed journal, which supports the descriptive facts about who did what and what was measured. Against that, the cluster has one publisher relaying one institutional release, no paper identifiers, no replication, and no adoption evidence, so the durability of the efficiency headline and the breadth of the application claims cannot be assessed from the material supplied.
science
A capped circular RNA and a branched lipid particle take aim at the dosing schedule1 distinct publisher
science
Myelin repair cells make their own stress hormone, and it seems to set the clock1 distinct publisher
science
A curing salt shows up in 164 UK death investigations, and the fix on offer is supply, not slogans1 distinct publisher
science
Bees eat less when pollen protein is wrong, which changes what pollinator planting has to solve1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 19, 2026